About

Some female athletes may have naturally higher levels of testosterone than others, and may be asked to consent to sex verification and either surgery or drugs to decrease testosterone levels. However, it has been reported that AndroGel, a transdermal gel formulation of testosterone, has become the most popular form of testosterone in androgen replacement therapy for hypogonadism in the United States. There are approved testosterone products for women in Australia, where it is considered a drug of dependence, medicines that are subject to misuse and trafficking, and some European countries.
Women who were menopausal due to ovariectomy showed significantly greater improvement in sexual function with testosterone relative to those who had normal menopause. These domains included frequency of sexual activity, orgasm, arousal, and sexual satisfaction, among others. Testosterone deficiency (also termed hypotestosteronism or hypotestosteronemia) is an abnormally low testosterone production.
In some of the cases, direct contact with the sites ofapplication on the skin of men using testosterone gel was reported. No testosterone gelpatients discontinued due to skin reaction. In this clinical trial oftestosterone gel, six patients had adverse events that led to theirdiscontinuation. Vogelxo is also supplied in a metered-dose pump thatdelivers 12.5 mg of testosterone per complete pump actuation. Vogelxo (testosterone) gel is a clear to translucenthydroalcoholic topical gel for topical use available in unit-dose tubes,unit-dose packets, and multiple-dose metered pumps.
There is suggestiveevidence that injection of testosterone into some strains of female miceincreases their susceptibility to hepatoma. Cases of secondaryexposure to testosterone have been reported in children. Free thyroid hormonelevels remain unchanged, however, and there is no clinical evidence of thyroiddysfunction. Gynecomastia occasionally develops and occasionallypersists in patients being treated for hypogonadism see ADVERSE REACTIONS.
Vogelxo provides continuous transdermal delivery of testosterone for 24 hours, following a single application to intact, clean, dry skin of the shoulders and/or upper arms. The ARs are expressed widely throughout the body, including in the penis, testicles, epididymides, prostate gland, seminal vesicles, fat, skin, bone, bone marrow, muscle, larynx, heart, liver, kidneys, pituitary gland, hypothalamus, and elsewhere throughout the brain. On the other hand, 5α-reductase inhibitors may prevent or reduce adverse androgenic side effects of testosterone like scalp hair loss, oily skin, acne, and seborrhea. However, when given to men with hypogonadism in the short- and medium-term, testosterone replacement therapy does not increase the risk of cardiovascular events (including strokes and heart attacks and other heart diseases). The FDA has required that testosterone pharmaceutical labels include warning information about the possibility of an increased risk of heart attacks and stroke.